Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institute of Cardiometabolism and Nutrition (ICAN) is a leading European research and clinical translation institute focused on cardiometabolic diseases, including obesity, diabetes, and NASH/MASH. Established as a Foundation for Scientific Cooperation, ICAN operates at the intersection of academic research and industrial development, providing specialized CRO services, biobanking, and multi-omics analysis. The institute leverages a massive clinical database and biological samples from the Pitié-Salpêtrière Hospital to accelerate the discovery of biomarkers and therapeutic targets. ICAN partners extensively with global pharmaceutical and biotech companies to conduct clinical trials and validate new therapeutic modalities in the cardiometabolic space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute of Cardio-metabolism.